Breast cancer screening in the older woman: An effective way to reduce mortality?

Maturitas

Volumn 66, Issue 3, 2010, Pages 263-267

  Paesmans, M ^a   Ameye, L ^a   Moreau, M ^a   Rozenberg, S ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Breast cancer mortality; Mammography; Randomized trials; Screening

Indexed keywords

BREAST CANCER; CANCER MORTALITY; CANCER SCREENING; CONFIDENCE INTERVAL; DIAGNOSTIC ACCURACY; FALSE POSITIVE RESULT; FOLLOW UP; HUMAN; MAMMOGRAPHY; MASTECTOMY; PUBLICATION; REVIEW; RISK ASSESSMENT; RISK REDUCTION;

EID: 77953020074     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2010.03.016     Document Type: Review

References (29)

1. Ameye L., Moreau M., and Paesmans M. Incidence and mortality in breast cancer: are we doing better?. Hospital Chronicles 2 (2007) 111-117
2. Glasziou P.P. Meta-analysis adjusting for compliance: the example of screening for breast cancer. J Clin Epidemiol 45 (1992) 1251-1256
3. NyströmL, Rutqvist L.E., Wall S., Lindgren A., Lindqvist M., Ryden S., Andersson I., Bjurstam N., Fagerberg G., and Frisell J. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 341 (1993) 973-978
4. Kerlikowske K., Grady D., Rubin S.M., Sandrock C., and Ernster V.L. Efficacy of screening of screening mammography: a meta-analysis. JAMA 273 2 (1995) 149-154
5. Demissie K., Mills O.F., and Rhoads G.G. Empirical comparison of the results of randomized controlled trials and case-control studies in evaluating the effectiveness of screening mammography. J Clin Epidemiol 51 2 (1998) 81-91
6. Olsen O., and Gotzsche P.C. Is screening for breast cancer with mammography justifiable?. Lancet 355 (2000) 129-134
7. Olsen O., and Gotzsche P.C. Cochrane review on screening from breast cancer with mammography. Lancet 358 (2001) 1340-1342
8. Nyström L., Andersson I., Bjurstam N., Frisell J., and Nordenskjold B. Long-term effects of mammography screening: updated overview of the Swedish randomized trials. Lancet 359 (2002) 909-919
9. Humphrey LL, et al. Screening for breast cancer. Systematic evidence review no15. Agency for Healthcare Research and Quality, Rockville, August 2002.
10. Nelson H.D., Tyne K., Naik A., Bougatsos C., Chan B.K., and Humphrey L. Screening for breast cancer: an update for the US Preventive Services Task Force. Ann Intern Med 151 (2009) 727-737
11. Mammographies et dépistage des cancers du sein. La Revue Prescrire 2006; 26:348-1/348-37.
12. Mammographic screening for breast cancer. Prescrire International 2008; 17:24-27.
13. Shapiro S., Venet W., Strax P., and Venet I. Periodic screening for breast cancer (1988), John Hopkins University Press, Baltimore
14. Tabar L., Vitak B., Chen H.H., et al. The Swedish two-county trial 20 years later: updated mortality results and new insights from long-term follow-up. Radiol Clin North Am 38 (2000) 625-651
15. Alexander F.E., Anderson T.J., Brown H.K., et al. 14 years of follow-up from the Edinburgh randomized trial of breast-cancer screening. Lancet 353 (1999) 1903-1908
16. Miller A.B., To T., Baines C.J., and Wall C. The Canadian National Breast Screening Study 1: breast cancer mortality after 11 to 16 years of follow-up. Ann Intern Med 137 (2002) E305-E315
17. Miller A.B., To T., Baines C.J., and Wall C. The Canadian National Breast Screening Study 2: 13-years results of a randomized trial in women aged 50-59 years. J Natl Cancer Inst 92 (2000) 1490-1499
18. Bjurstam N., Bjorneld I., Warwick J., et al. The Gothenburg breast screening trial. Am Can Soc 97 (2003) 2387-2396
19. Moss S.M., Cuckle H., Evans A., Johns L., Waller M., Bobrow L., and for the trial management group. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial. Lancet 368 (2006) 2053-2060
20. Gøtzsche P.C., and Nielsen M. Cochrane Database Syst Rev 18 October 4 (2006) CD001877
21. Chu K.C., Smart C.R., and Tarone R.E. Analysis of breast cancer mortality and stage distribution by age for the Health I nsurance Plan clinical trial. J Natl Cancer Inst 80 (1988) 1125-1132
22. Smith R.A., Salou D., Sawyer K.A., Burke W., Costanza M.E., Evans W.P., Foster R.S., Hendrick E., Eyre H.J., and Sener S. American Cancer Society guidelines for breast cancer screening: update 2003. Ca Cancer J Clin 53 (2003) 141-169
23. US Preventive Services Task Force. Screening for breast cancer: US Preventive Services task Force Recommendation Statement. Ann Intern Med 2009; 151:716-726.
24. Tabar L., Fagerberg G., Chen H.H., et al. Efficacy of breast cancer screening by age. New results from the Swedish Two-County trial. Cancer 75 (1995) 2507-2517
25. Berry D.A., Cronin K.A., Plevritis S.K., et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353 (2005) 1784-1792
26. Keen J.D., and Keen J.E. What is the point: will screening mammography save my life?. BMC Med Inform Decis Making 9 (2009) 18
27. Jorgensen K. Mammography screening is not as good as we hoped. Maturitas 65 (2010) 1-2
28. Wilson J.M.G., and Jungner G. Principles and practice of screening for disease. Public Health Papers nr 34 (1968), WHO, Geneva
29. http://www.epicentro.iss.it/problemi/tumori/reslet.pdf (accessed 21.01.2010).